Association between elevated red blood cell distribution width and long-term mortality in acute pulmonary embolism
Background/aim: The prognostic value of the red cell distribution width (RDW) as a cost-effective and noninvasive test in acute pulmonary embolism (PE) is still unknown. We aimed to investigate the prognostic value of the admission RDW level in the long-term survival of PE patients. Materials and me...
Gespeichert in:
Veröffentlicht in: | Turkish journal of medical sciences 2018-04, Vol.48 (2), p.318-323 |
---|---|
Hauptverfasser: | , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Background/aim:
The prognostic value of the red cell distribution width (RDW) as a cost-effective and noninvasive test in acute
pulmonary embolism (PE) is still unknown. We aimed to investigate the prognostic value of the admission RDW level in the long-term
survival of PE patients.
Materials and methods:
In this registry-based, prospective cohort study, a total of 378 patients (mean age: 60.4 ± 17.11 years, 47.4%
female) who presented with acute PE were enrolled. All the clinical data for each patient were obtained from our institutional PE
registry. The follow-up was performed at a median time of 17 months. The primary endpoint was death at follow-up.
Results:
The mean RDW in study patients was 14.67 ± 2.13. The all-cause mortality rate during the follow-up was 15.6% (n = 59). After
adjustment for potential confounders, the relationship between RDW and long-term mortality showed a trend of a significant level
(hazard ratio: 1.109; 95% CI, 0.998−1.232; P = 0.053). We divided patients into 3 groups based on the European Society of Cardiology’s
classification. As we moved from the low risk to the higher risk categories, the mean RDW increased significantly (P = 0.037).
Conclusion:
It seems there may be an independent association between RDW at presentation and PE mortality within 17 months. |
---|---|
ISSN: | 1300-0144 1303-6165 |
DOI: | 10.3906/sag-1709-46 |